Hercelin B, Leroy P, Nicolas A, Gavriloff C, Chassard D, Thébault J J, Reveillaud M T, Salles M F, Netter P
Unité de Pharmacocinétique-Biopharmacie, Laboratoires Cassenne, Osny, France.
Eur J Clin Pharmacol. 1992;43(1):93-5. doi: 10.1007/BF02280762.
We have studied the pharmacokinetics of tiopronin and its principal metabolite, 2-mercaptopropionic acid (2-MPA) in healthy volunteers after the oral administration of 500 mg (2 Acadione tablets), followed by simultaneous assay of the two compounds in plasma over a period of 48 h using a new method (emission of fluorescence after HPLC and post-column derivatization by pyrene-maleimide). The absorption of tiopronin was slow (tmax between 4 and 6 h) and the plasma concentrations subsequently fell biexponentially. The principal metabolite 2-MPA appeared later in the plasma (tmax between 10 and 12 h after a lag-time of 3 h) then disappeared monoexponentially. About 15% of the tiopronin was metabolized to 2-MPA.
我们研究了硫普罗宁及其主要代谢产物2-巯基丙酸(2-MPA)在健康志愿者口服500毫克(2片阿克迪翁片)后的药代动力学,随后使用一种新方法(高效液相色谱后经芘-马来酰亚胺柱后衍生化后荧光发射)在48小时内同时测定血浆中的这两种化合物。硫普罗宁的吸收缓慢(达峰时间在4至6小时之间),随后血浆浓度呈双指数下降。主要代谢产物2-MPA在血浆中出现较晚(在3小时的滞后时间后,达峰时间在10至12小时之间),然后呈单指数消失。约15%的硫普罗宁代谢为2-MPA。